Barcelona patent court finds oxycodone and naloxone patent invalid due to added matter

On 19 December 2018 Barcelona Commercial Court Number 4 dismissed a patent infringement action brought by Mundipharma against two generics of its oxycodone and naloxone medicinal product for the treatment of pain (Targin) and upheld the defendants’ counterclaim that the asserted patent was invalid. Facts Mundipharma holds European Patent EP2425825 (EP’825), entitled ‘Pharmaceutical preparation containing…

Details

Teleshopping ads found to infringe copyright

On 25 July 2018 Barcelona Commercial Court Number 2 declared that teleshopping ads broadcast by European Home Shopping, SL (the defendant) had infringed the copyright in three similar ads created by Telebrands Corp, International Edge, Inc and Best Option Products SL (the plaintiffs). Read More

Details